IMO a new 52 week high (over $6.31) on or just before CTAD on November 6th is practically a given. I actually wouldn't be shocked to see AVXL break $8 on that date. As always, time will tell. Once again, I will be more than happy to stop riding the "trolley" and just watch AVXL run up beyond $10 and leave these single digit prices in the dust forever...
Question: How soon do companies usually get FDA guidance after data has been submitted for future trials? When can we expect Anavex to communicate FDA guidance on further PDD/PD studies?
News 
Market Data 
Discover 
